Trapidil (triazolopyrimidine), a platelet-derived growth...

Circulation 1994 / 12 Vol. 90; Iss. 6

Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica

Maresta, A., Balducelli, M., Cantini, L., Casari, A., Chioin, R., Fabbri, M., Fontanelli, A., Monici Preti, P. A., Repetto, S., De Servi, S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
90
Language:
english
Journal:
Circulation
DOI:
10.1161/01.CIR.90.6.2710
Date:
December, 1994
File:
PDF, 1.32 MB
english, 1994
Conversion to is in progress
Conversion to is failed